The Filing Desk

Cryo Cell International vs Exagen

Cryo Cell International CCEL · Exagen XGN · Health Care Services

Exagen reported revenue of $67 million in fiscal 2025, 2.1 times Cryo Cell International's $32 million in fiscal 2025. Cryo Cell International's revenue fell 1.3% in its latest year, and Exagen's grew 19.6%. Cryo Cell International had an operating margin of 1.5%, against -21.1% at Exagen. Free cash flow was $5 million at Cryo Cell International and −$14 million at Exagen. Their fiscal years end in different months (November 30 and December 31), so the periods don't line up exactly.

Side by side

Cryo Cell InternationalExagen
Latest fiscal yearFY2025, Nov 30, 2025FY2025, Dec 31, 2025
Revenue$32M$67M
Revenue growth−1.3%19.6%
Revenue growth a year, last 5 years0.3%9.7%
Gross margin76.6%58.3%
Operating margin1.5%−21.1%
Net margin−7.7%−30.0%
Free cash flow$5M−$14M
Free cash flow margin16.6%−21.4%
Return on capital—−115.0%
Net debt to EBITDA3.5x—
Dividends and buybacks$3M$0M
Change in diluted share count−1.8%18.4%
Last close$4.15$3.80
P/E at the last close——
Insider trades, last 12 months—sold $252,640
Piotroski F-score6 of 93 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Cryo Cell InternationalExagen
Operating margin
Percent of revenue
Cryo Cell InternationalExagen
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Cryo Cell InternationalExagen

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Cryo Cell International and Exagen pages.